Paper39757201
GPR40-full agonist AM1638 alleviates palmitate-induced oxidative damage in H9c2 cells via an AMPK-dependent pathway.
Yun S and 9 others. BMB Rep, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. GPR40-full agonist AM1638 alleviates palmitate-induced oxidative damage in H9c2 cells via an AMPK-dependent pathway. Papers, record 39757201. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39757201
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- GPR40-full agonist AM1638 alleviates palmitate-induced oxidative damage in H9c2 cells via an AMPK-dependent pathway.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Oxidative Stress | Major topic |
| Receptors, G-Protein-Coupled | Major topic |
| AMP-Activated Protein Kinases | Major topic |
| Palmitates | Major topic |
| Animals | |
| Rats | |
| Myocytes, Cardiac | |
| Cell Line | |
| Signal Transduction | |
| Membrane Potential, Mitochondrial | |
| Cell Survival | |
| Phosphorylation | |
| Apoptosis |
Source PubMed
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35067013 | GPR40 Agonism Modulates Inflammatory Reactions in Vascular Endothelial Cells. | Diabetes Metab J | 2022 | https://conductscience.org/library/papers/35067013 | PubMed |
| 2 | 20141097 | Cardiomyopathy: an overview. | Am Fam Physician | 2009 | https://conductscience.org/library/papers/20141097 | PubMed |
| 3 | 24096871 | Cell death and diseases related to oxidative stress: 4-hydroxynonenal (HNE) in the balance. | Cell Death Differ | 2013 | https://conductscience.org/library/papers/24096871 | PubMed |
| 4 | 35040256 | Mitophagy-regulated mitochondrial health strongly protects the heart against cardiac dysfunction after acute myocardial infarction. | J Cell Mol Med | 2022 | https://conductscience.org/library/papers/35040256 | PubMed |
| 5 | 32719069 | The GPR40 Full Agonist SCO-267 Improves Liver Parameters in a Mouse Model of Nonalcoholic Fatty Liver Disease without Affecting Glucose or Body Weight. | J Pharmacol Exp Ther | 2020 | https://conductscience.org/library/papers/32719069 | PubMed |
| 6 | 25685685 | GPR40 (FFAR1) - Combined Gs and Gq signaling in vitro is associated with robust incretin secretagogue action ex vivo and in vivo. | Mol Metab | 2015 | https://conductscience.org/library/papers/25685685 | PubMed |
| 7 | 35203602 | Involvement of Oxidative Stress in the Development of Subcellular Defects and Heart Disease. | Biomedicines | 2022 | https://conductscience.org/library/papers/35203602 | PubMed |
| 8 | 29695780 | Structural basis for GPR40 allosteric agonism and incretin stimulation. | Nat Commun | 2018 | https://conductscience.org/library/papers/29695780 | PubMed |
| 9 | 27121981 | GPR40 agonist ameliorates liver X receptor-induced lipid accumulation in liver by activating AMPK pathway. | Sci Rep | 2016 | https://conductscience.org/library/papers/27121981 | PubMed |
| 10 | 27138700 | HO-1 Protects against Hypoxia/Reoxygenation-Induced Mitochondrial Dysfunction in H9c2 Cardiomyocytes. | PLoS One | 2016 | https://conductscience.org/library/papers/27138700 | PubMed |
| 11 | 30291911 | Augmentation of NAD+ levels by enzymatic action of NAD(P)H quinone oxidoreductase 1 attenuates adriamycin-induced cardiac dysfunction in mice. | J Mol Cell Cardiol | 2018 | https://conductscience.org/library/papers/30291911 | PubMed |
| 12 | 22833723 | Heme oxygenase-1, oxidation, inflammation, and atherosclerosis. | Front Pharmacol | 2012 | https://conductscience.org/library/papers/22833723 | PubMed |
| 13 | 24666736 | CNX-011-67, a novel GPR40 agonist, enhances glucose responsiveness, insulin secretion and islet insulin content in n-STZ rats and in islets from type 2 diabetic patients. | BMC Pharmacol Toxicol | 2014 | https://conductscience.org/library/papers/24666736 | PubMed |
| 14 | 33262575 | Agonism of Gpr40 Protects the Capacities of Epidermal Stem Cells (ESCs) Against Ultraviolet-B (UV-B). | Drug Des Devel Ther | 2020 | https://conductscience.org/library/papers/33262575 | PubMed |
| 15 | 31857574 | Mitochondrial dysfunction and oxidative stress in heart disease. | Exp Mol Med | 2019 | https://conductscience.org/library/papers/31857574 | PubMed |
| 16 | 24974801 | Activation of GPR40 attenuates chronic inflammation induced impact on pancreatic β-cells health and function. | BMC Cell Biol | 2014 | https://conductscience.org/library/papers/24974801 | PubMed |
| 17 | 19808358 | Control by circulating factors of mitochondrial function and transcription cascade in heart failure: a role for endothelin-1 and angiotensin II. | Circ Heart Fail | 2009 | https://conductscience.org/library/papers/19808358 | PubMed |
| 18 | 31395314 | Cardiac Metabolic Limitations Contribute to Diminished Performance of the Heart in Aging. | Biophys J | 2019 | https://conductscience.org/library/papers/31395314 | PubMed |
| 19 | 34497589 | GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects. | Front Endocrinol (Lausanne) | 2021 | https://conductscience.org/library/papers/34497589 | PubMed |
| 20 | 37915121 | AM1638, a GPR40-Full Agonist, Inhibited Palmitate- Induced ROS Production and Endoplasmic Reticulum Stress, Enhancing HUVEC Viability in an NRF2-Dependent Manner. | Endocrinol Metab (Seoul) | 2023 | https://conductscience.org/library/papers/37915121 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42444033 | GW9508-Induced Activation of GPR40 in Thymic Epithelial Cells: A Therapeutic Strategy to Delay Thymic Aging. | Aging Cell | 2026 | https://conductscience.org/library/papers/42444033 | PubMed |
| 42371471 | Activation of G protein-coupled receptor 40 alleviates STAT6 activation, airway inflammation and mucus hypersecretion in allergic asthma. | Curr Res Pharmacol Drug Discov | 2026 | https://conductscience.org/library/papers/42371471 | PubMed |
| 42008849 | The zinc-nitric oxide axis in acute brain injury: Convergent oxidative-nitrative stress, peroxynitrite signaling, and therapeutic targets. | Redox Biol | 2026 | https://conductscience.org/library/papers/42008849 | PubMed |
| 41552010 | 4-HNE-induced cellular dysfunction from lipid peroxidation: a potential therapeutic target in diabetic cardiomyopathy. | Front Cell Dev Biol | 2025 | https://conductscience.org/library/papers/41552010 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39757201
GET https://conductscience.org/api/papers/v1/39757201/references?page=2